Consensus STERIS plc

Equities

STE

IE00BFY8C754

Market Closed - Nyse Other stock markets 04:00:02 2024-05-14 pm EDT			5-day change	1st Jan Change
236 ^USD	+1.48%		+10.87%	+7.35%

May. 10	Wolfe Research Adjusts Price Target on STERIS to $240 From $235	MT
May. 10	Piper Sandler Adjusts Price Target on STERIS to $225 From $220	MT

Evolution of the average Target Price on STERIS plc

Price target over the last 5 years

History of analyst recommendation changes

68912e7104dc81643cdbe44a.13VQ-VUvCaMj26lfkySDGcrODeRYmKTZQwqIPNKETR8.5kNnrCZiT_dwkPYOw0WxerK_YLMh8MDpFUClX-b3G1ShBiCXIXg4m3G_4A~6899298c8c5c8127c38aa2951442880a

Analyst Recommendations on STERIS plc

Wolfe Research Adjusts Price Target on STERIS to $240 From $235	May. 10	MT
Piper Sandler Adjusts Price Target on STERIS to $225 From $220	May. 10	MT
KeyBanc Adjusts Price Target on STERIS to $255 From $253	May. 10	MT
Wolfe Research Adjusts STERIS Price Target to $235 From $245	Apr. 19	MT
Morgan Stanley Cuts Price Target on STERIS to $215 From $225, Keeps Equalweight Rating	Dec. 04	MT
ANALYST RECOMMENDATIONS : Biogen, Conocophillips, Kellanova, Take Two, Tesla...	Nov. 09
Piper Sandler Adjusts Price Target on STERIS to $215 From $220, Maintains Neutral Rating	23-10-27	MT
All hail the resilience of the US economy	23-10-26
ANALYST RECOMMENDATIONS : Adobe, Live Nation, Meta, Snap, Wpp...	23-10-26
JMP Securities Adjusts STERIS' Price Target to $265 From $240, Keeps Market Outperform Rating	23-09-01	MT
Morgan Stanley Adjusts Price Target on STERIS to $225 From $206, Maintains Equalweight Rating	23-08-03	MT
KeyBanc Adjusts Price Target on STERIS to $258 From $254, Maintains Overweight Rating	23-08-03	MT
KeyBanc Lifts Price Target on STERIS to $254 From $235, Says Initial Guidance 'Likely Conservative,' Keeps Overweight Rating	23-07-25	MT
Stephens Adjusts STERIS' Price Target to $250 From $240, Keeps Overweight Rating	23-07-17	MT
Morgan Stanley Initiates Coverage on STERIS With Equal Weight Rating, $206 Price Target	23-05-30	MT
Piper Sandler Adjusts Price Target on STERIS to $200 From $197, Keeps Neutral Rating	23-05-12	MT
Keybanc Adjusts Price Target on STERIS to $235 From $210, Keeps Overweight Rating	23-05-12	MT
Piper Sandler Downgrades STERIS to Neutral From Overweight, Adjusts Price Target to $197 From $215	23-04-14	MT
Piper Sandler Cuts Price Target on STERIS to $215 From $235, Maintains Overweight Rating	23-02-10	MT
KeyBanc Adjusts STERIS' Price Target to $210 From $240, Keeps Overweight Rating	22-11-11	MT
Needham Downgrades STERIS to Hold From Buy on Capital Equipment Exposure, Potential Ethylene Oxide Liabilities; $237 Price Target Removed	22-09-23	MT
KeyBanc Adjusts STERIS' Price Target to $240 From $256, Reiterates Overweight Rating	22-08-04	MT
Piper Sandler Adjusts STERIS' Price Target to $235 From $240, Reiterates Overweight Rating	22-08-03	MT
Needham Cuts STERIS' Price Target to $237 From $248 Following FY Guidance Cut, Reiterates Buy Rating	22-08-03	MT
Piper Sandler Starts STERIS at Overweight With $240 Price Target	22-07-14	MT